Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Neurology

Journal Scan / Research · August 18, 2022

The Boston Criteria Version 2.0 for Cerebral Amyloid Angiopathy

The Lancet Neurology


Additional Info

The Lancet Neurology
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study
Lancet Neurol 2022 Aug 01;21(8)714-725, A Charidimou, G Boulouis, MP Frosch, JC Baron, M Pasi, JF Albucher, G Banerjee, C Barbato, F Bonneville, S Brandner, L Calviere, F Caparros, B Casolla, C Cordonnier, MB Delisle, V Deramecourt, M Dichgans, E Gokcal, J Herms, M Hernandez-Guillamon, HR Jäger, Z Jaunmuktane, J Linn, S Martinez-Ramirez, E Martínez-Sáez, C Mawrin, J Montaner, S Moulin, JM Olivot, F Piazza, L Puy, N Raposo, MA Rodrigues, S Roeber, JR Romero, N Samarasekera, JA Schneider, S Schreiber, F Schreiber, C Schwall, C Smith, L Szalardy, P Varlet, A Viguier, JM Wardlaw, A Warren, FA Wollenweber, M Zedde, MA van Buchem, ME Gurol, A Viswanathan, R Al-Shahi Salman, EE Smith, DJ Werring, SM Greenberg

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading